Brain zaps and flickering lights: a new memory hack?
NCT ID NCT07668167
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 4 times
Summary
This study tests whether combining 40Hz light, sound, and mild nerve stimulation can improve working memory in healthy adults. Thirty participants will try different combinations of these non-invasive stimulations while their brain activity is recorded. The goal is to understand how these techniques affect brain networks and whether they can enhance cognitive function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal how combining different types of brain stimulation might improve memory or focus.
- What could go wrong
- This is a small, early-phase study in healthy people, so results may not apply to patients or lead to a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy adults aged ≥18 years old. * Normal or corrected-to-normal vision and hearing (essential for 40Hz visual and auditory stimulation). * Right-handedness. * Willing to participate in the study and capable of providing written informed consent. Exclusion Criteria: * Personal or family history of epilepsy or seizures (crucial safety criteria for 40Hz flicker and electrical stimulation). * History of any neurological or psychiatric disorders. * Presence of metallic implants in the head, cardiac pacemakers, or other implanted electronic medical devices. * Skin lesions, infections, or hypersensitivity at the eTNS stimulation site (maxillary branch of the trigeminal nerve). * Current use of psychoactive medications or substances that may significantly alter EEG signals or brain state dynamics. * Pregnant or lactating individuals. * Poor sleep quality or irregular sleep-wake cycles prior to the experiment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy participants are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Xidian University
RECRUITINGXi'an, Shaanxi, 71000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body